(0.24%) 5 559.25 points
(0.01%) 39 552 points
(0.38%) 20 117 points
(0.67%) $82.29
(0.86%) $2.71
(0.00%) $2 336.70
(1.75%) $29.43
(1.89%) $1 010.40
(0.16%) $0.935
(0.45%) $10.68
(0.04%) $0.791
(1.77%) $86.50
0.00% HKD 4.66
Live Chart Being Loaded With Signals
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials...
Stats | |
---|---|
Dzisiejszy wolumen | 527 405 |
Średni wolumen | 4.37M |
Kapitalizacja rynkowa | 16.32B |
EPS | HKD0.240 ( Q4 | 2023-12-31 ) |
Last Dividend | HKD0.140 ( 2023-06-09 ) |
Next Dividend | HKD0 ( N/A ) |
P/E |
8.63 (Sector) 14.27 (Industry) 0 |
ATR14 | HKD0.00800 (0.17%) |
Wolumen Korelacja
China Grand Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
China Grand Korelacja - Waluta/Towar
China Grand Finanse
Annual | 2023 |
Przychody: | HKD10.53B |
Zysk brutto: | HKD6.52B (61.96 %) |
EPS: | HKD0.540 |
FY | 2023 |
Przychody: | HKD10.53B |
Zysk brutto: | HKD6.52B (61.96 %) |
EPS: | HKD0.540 |
FY | 2022 |
Przychody: | HKD9.56B |
Zysk brutto: | HKD5.95B (62.24 %) |
EPS: | HKD0.590 |
FY | 2021 |
Przychody: | HKD8.60B |
Zysk brutto: | HKD5.25B (61.03 %) |
EPS: | HKD0.677 |
Financial Reports:
No articles found.
China Grand Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.140 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0860 | 2019-06-12 |
Last Dividend | HKD0.140 | 2023-06-09 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | HKD0.542 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.54 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.64 | |
Div. Directional Score | 9.96 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
09 Jun 2023 | HKD0.140 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
06 Jun 2022 | HKD0.110 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
08 Jun 2021 | HKD0.110 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 Jun 2020 | HKD0.0960 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
12 Jun 2019 | HKD0.0860 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
1443.HK | Ex Dividend Junior | 2023-10-04 | Annually | 0 | 0.00% | |
0046.HK | Ex Dividend Knight | 2023-08-31 | Semi-Annually | 0 | 0.00% | |
3848.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
0991.HK | Ex Dividend Junior | 2023-06-30 | Sporadic | 0 | 0.00% | |
2196.HK | Ex Dividend Junior | 2023-07-31 | Annually | 0 | 0.00% | |
0595.HK | Ex Dividend Junior | 2023-09-06 | Annually | 0 | 0.00% | |
1723.HK | Ex Dividend Junior | 2023-09-04 | Sporadic | 0 | 0.00% | |
0173.HK | Ex Dividend Junior | 2023-09-12 | Semi-Annually | 0 | 0.00% | |
6868.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
1234.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.179 | 1.500 | 6.43 | 9.64 | [0 - 0.5] |
returnOnAssetsTTM | 0.0835 | 1.200 | 7.22 | 8.66 | [0 - 0.3] |
returnOnEquityTTM | 0.127 | 1.500 | 9.70 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.264 | -1.000 | 7.36 | -7.36 | [0 - 1] |
currentRatioTTM | 1.224 | 0.800 | 8.88 | 7.10 | [1 - 3] |
quickRatioTTM | 0.843 | 0.800 | 9.75 | 7.80 | [0.8 - 2.5] |
cashRatioTTM | 0.239 | 1.500 | 9.78 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.148 | -1.500 | 7.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 12.98 | 1.000 | 6.30 | 6.30 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.636 | 2.00 | 9.79 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.494 | 2.00 | 9.75 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.221 | -1.500 | 9.12 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.620 | 1.000 | 3.01 | 3.01 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.253 | 1.000 | 6.94 | 6.94 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.667 | 1.000 | 7.41 | 7.41 | [0.2 - 2] |
assetTurnoverTTM | 0.468 | 0.800 | -0.216 | -0.172 | [0.5 - 2] |
Total Score | 12.28 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.62 | 1.000 | 9.23 | 0 | [1 - 100] |
returnOnEquityTTM | 0.127 | 2.50 | 9.81 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.494 | 2.00 | 9.84 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.62 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.636 | 2.00 | 9.79 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.264 | 1.500 | 7.36 | -7.36 | [0 - 1] |
pegRatioTTM | 0.650 | 1.500 | 9.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.212 | 1.000 | 7.21 | 0 | [0.1 - 0.5] |
Total Score | 7.64 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
China Grand
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare disease medicines. It also provides medical devices, such as vascular interventional medical devices comprising paclitaxel releasing coronary balloon dilatation catheters and paclitaxel releasing hemodialysis shunt balloon dilatation catheters; and ophthalmology related devices. In addition, the company offers biotechnology and health products, such as Taurine, amino acid products, steroid products, and bio-pesticides and agricultural antibiotics; and specialized pharmaceutical raw materials and other products, including metronidazole, chloramphenicol, epinephrine, dimethyl sulfate, nitromethane, etc. Further, the company offers agrochemicals, fine chemicals, and chemical medicines; ophthalmic gel and eye drops; steroid hormones active pharmaceutical ingredients and related intermediates; bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited and changed its name to Grand Pharmaceutical Group Limited in November 2021. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej